3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Thyroid Cancer, Papillary
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Lymphoma
1
Immunoglobulin Light-chain Amyloidosis
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Endometrial Neoplasms
1
Interventions
pembrolizumab
14
Carboplatin
12
Specimen Handling
10
sacituzumab govitecan
6
Magnetic Resonance Spectroscopy
6
Capecitabine
6
Biopsy
6
Paclitaxel
5
Gemcitabine
5
Nivolumab
4
Cyclophosphamide
4
olaparib
3
Taxes
3
Fulvestrant
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Platinum
2
Letrozole
2
Immunoglobulin G
2
Epirubicin
2
Albumin-Bound Paclitaxel
2
zimberelimab
1
vistusertib
1
veliparib
1
tremelimumab
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Phantoms, Imaging
×
30 days
×
Clear all
No trials found.